Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
77.24
-2.09 (-2.63%)
Sep 18, 2026, 4:00 PM EDT - Market closed
KNSA Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,027 | 3,127 | 1,428 | 1,234 | 1,042 | 811 | |
Market Cap Growth | 129.53% | 118.92% | 15.76% | 18.45% | 28.46% | -32.59% |
Enterprise Value | 5,510 | 2,784 | 1,215 | 1,046 | 848 | 617 |
Last Close Price | 77.24 | 41.25 | 19.78 | 17.54 | 14.98 | 11.77 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 78.00 | 52.99 | - | 87.60 | 5.68 | - |
Forward PE | 54.30 | 27.32 | 42.93 | 170.84 | 170.84 | - |
PS Ratio | 7.17 | 4.61 | 3.37 | 4.57 | 4.73 | 21.04 |
PB Ratio | 9.21 | 5.51 | 3.26 | 2.81 | 2.63 | 4.38 |
P/TBV Ratio | 9.43 | 5.66 | 3.38 | 2.93 | 2.76 | 4.89 |
P/FCF Ratio | 32.96 | 22.92 | 56.20 | 93.67 | 182.67 | - |
P/OCF Ratio | 32.58 | 22.66 | 55.59 | 92.76 | 179.37 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.55 | 4.11 | 2.87 | 3.87 | 3.85 | 16.02 |
EV/EBITDA Ratio | 53.99 | 35.34 | - | - | 69.62 | - |
EV/EBIT Ratio | 54.96 | 36.06 | - | - | 86.73 | - |
EV/FCF Ratio | 30.13 | 20.41 | 47.81 | 79.39 | 148.64 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 |
Debt / EBITDA Ratio | 0.08 | 0.11 | - | - | 0.38 | - |
Debt / FCF Ratio | 0.05 | 0.07 | 0.39 | 0.93 | 1.04 | - |
Net Debt / Equity Ratio | -0.79 | -0.71 | -0.53 | -0.44 | -0.47 | -0.95 |
Net Debt / EBITDA Ratio | -5.07 | -5.14 | 5.32 | 8.49 | -15.17 | 1.14 |
Net Debt / FCF Ratio | -2.83 | -2.97 | -9.20 | -14.74 | -32.39 | 1.39 |
Asset Turnover | 1.08 | 1.01 | 0.77 | 0.55 | 0.64 | 0.13 |
Inventory Turnover | 6.42 | 7.56 | 6.58 | 3.41 | 3.72 | - |
Quick Ratio | 3.21 | 3.09 | 2.84 | 3.58 | 4.48 | 4.15 |
Current Ratio | 3.90 | 3.79 | 3.30 | 4.34 | 5.16 | 4.38 |
Return on Equity (ROE) | 14.04% | 11.73% | -9.85% | 3.37% | 63.10% | -63.55% |
Return on Assets (ROA) | 8.05% | 7.18% | -5.15% | -3.19% | 1.76% | -33.63% |
Return on Invested Capital (ROIC) | 49.89% | 27.89% | -20.30% | -11.05% | 8.87% | -7244.96% |
Return on Capital Employed (ROCE) | 13.80% | 12.40% | -9.50% | -5.40% | 2.40% | -83.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.34% | 1.89% | -3.02% | 1.14% | 17.60% | -19.48% |
FCF Yield | 3.03% | 4.36% | 1.78% | 1.07% | 0.55% | -15.63% |
Buyback Yield / Dilution | -9.97% | -10.58% | 0.69% | -2.13% | -2.69% | -10.89% |